Insights from Preclinical Disease Modeling in Ophthalmic Gene Therapy
Time: 2:30 pm
day: Day Two 12th
Details:
- Delving into the intricacies of preclinical disease modeling, exploring how advanced techniques and diverse disease models inform the development of effective ophthalmic gene therapies
- Gaining valuable insights into prioritizing preclinical research efforts, focusing on key aspects such as vector engineering, delivery routes, and expression data to optimize therapeutic strategies for optic disorders
- Exploring the journey from preclinical to clinical research, uncovering the pivotal role of disease modeling in designing regulatory pathways and translating promising therapies from bench to bedside